🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

10,225 results for “He” Clear

  1. hydrochloride hydromorphone + flurbiprofen axetil

    The First People's Hospital of Lianyungang

    Enhanced Recovery After Surgery

    approved small molecule completed

    1 trial

  2. hylan G-F 20

    United Therapeutics Europe Ltd

    Osteoarthritis, Knee

    approved other completed

    1 trial

  3. hylenex-facilitated subcutaneous Lactated Ringer's infusion

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule completed

    1 trial

  4. ibandronate [Bonviva/Boniva]

    Hoffmann-La Roche

    Post Menopausal Osteoporosis

    approved small molecule completed

    1 trial

  5. iloperidone

    Vanda Pharmaceuticals Netherlands B.V.

    Bipolar Disorder

    approved small molecule completed

    1 trial

  6. imiquimod

    United Therapeutics Europe Ltd

    Anal Dysplasia

    approved small molecule terminated

    1 trial

  7. inhaled treprostinil

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule terminated

    3 trials

  8. insulin lispro injection, exenatide injection

    The First People's Hospital of Lianyungang

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  9. intravenous tranexamic acid (TXA) infusion

    The First People's Hospital of Lianyungang

    Spontaneous Intracranial Hemorrhage

    approved small molecule active

    1 trial

  10. iodixanol

    The First People's Hospital of Lianyungang

    Kidney Failure, Chronic

    approved small molecule active

    1 trial

  11. iron and zinc combined

    United Therapeutics Europe Ltd

    Anemia

    approved other completed

    1 trial

  12. isoniazid, rifampin, pyrazinamide

    Hospital Authority, Hong Kong

    Hepatitis

    approved small molecule active

    1 trial

  13. ketamine

    United Therapeutics Europe Ltd

    Acute Pain

    approved small molecule terminated

    1 trial

  14. ketamine

    Cardiff Oncology

    Healthy Volunteers

    approved small molecule completed

    1 trial

  15. lamivudine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Compensated Chronic Hepatitis B

    approved small molecule completed

    1 trial

  16. large protein molecule

    HALOZYME THERAPEUTICS, INC.

    Rheumatoid Arthritis

    approved small molecule completed

    1 trial

  17. lorlatinib

    The First People's Hospital of Lianyungang

    NSCLC

    approved small molecule active

    1 trial

  18. low-dose tenecteplase intravenous thrombolysis

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke Patients

    approved small molecule active

    1 trial

  19. low-dose ticagrelor

    The First People's Hospital of Lianyungang

    Platelet Reactivity

    approved small molecule completed

    1 trial

  20. low-dose ticagrelor

    The First People's Hospital of Lianyungang

    Coronary Artery Disease

    approved small molecule active

    1 trial

  21. lubiprostone

    Takeda

    Healthy

    approved small molecule completed

    1 trial

  22. mebeverine

    United Therapeutics Europe Ltd

    Irritable Bowel Syndrome

    approved small molecule completed

    1 trial

  23. metformin

    Boehringer Ingelheim

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  24. methadone

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources